124 related articles for article (PubMed ID: 31777596)
1. A Systematic Inflammation-based Model in Advanced Pancreatic Ductal Adenocarcinoma.
Wu LX; Wang XY; Xu KQ; Lin YL; Zhu WY; Han L; Shao YT; Zhou HY; Jiang H; Hang JJ; Yang XG
J Cancer; 2019; 10(26):6673-6680. PubMed ID: 31777596
[TBL] [Abstract][Full Text] [Related]
2. Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction.
Pu N; Yin H; Zhao G; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Cancer; 2019; 10(24):5935-5943. PubMed ID: 31762803
[No Abstract] [Full Text] [Related]
3. Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.
Pu N; Gao S; Xu Y; Zhao G; Lv Y; Nuerxiati A; Li JA; Wang D; Xu X; Kuang T; Wang X; Lou W; Liu L; Wu W
J Cancer; 2017; 8(16):3362-3370. PubMed ID: 29158809
[No Abstract] [Full Text] [Related]
4. A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma.
Zhang LX; Chen L; Xu AM
Front Oncol; 2020; 10():583. PubMed ID: 32426277
[No Abstract] [Full Text] [Related]
5. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pre-treatment peripheral blood markers in pancreatic ductal adenocarcinoma and their association with S100A4 expression in tumor tissue.
Li H; Tian X; Xu Y; Pan Y; Huang Y; Zhou D; Song Z
Oncol Lett; 2019 Nov; 18(5):4523-4534. PubMed ID: 31611961
[TBL] [Abstract][Full Text] [Related]
7. A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma.
Liu JS; Huang Y; Yang X; Feng JF
Am J Cancer Res; 2015; 5(7):2180-9. PubMed ID: 26328248
[TBL] [Abstract][Full Text] [Related]
8. A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection.
He C; Sun S; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():1564. PubMed ID: 33014805
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study.
He C; Zhong L; Zhang Y; Cai Z; Lin X
Cancer Manag Res; 2019; 11():3981-3991. PubMed ID: 31118811
[No Abstract] [Full Text] [Related]
10. Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.
Zhuang H; Zhou Z; Ma Z; Huang S; Gong Y; Li Z; Liu C; Wang S; Chen B; Zhang C; Hou B
Clin Med Insights Oncol; 2021; 15():11795549211024149. PubMed ID: 34211308
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.
Ren H; Wu CR; Aimaiti S; Wang CF
Oncol Lett; 2020 Jun; 19(6):4093-4105. PubMed ID: 32382348
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma.
Li H; Zhou F; Cao Z; Tang Y; Huang Y; Li Y; Yi B; Yang J; Du P; Zhu D; Zhou J
Front Oncol; 2021; 11():682969. PubMed ID: 34136406
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer.
Zhang Y; Xu Y; Wang D; Kuang T; Wu W; Xu X; Jin D; Lou W
Int J Clin Oncol; 2021 Jan; 26(1):135-144. PubMed ID: 32959232
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Inflammatory Biomarkers in Gastric Cancer Patients and the Construction of a Predictive Model.
Ma M; Wang J; Hu Y; Weng M; Liu X; Wang Y
Dig Surg; 2019; 36(5):433-442. PubMed ID: 30300879
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy.
Asama H; Suzuki R; Takagi T; Sugimoto M; Konno N; Watanabe K; Nakamura J; Kikuchi H; Takasumi M; Sato Y; Irie H; Hikichi T; Ohira H
Mol Clin Oncol; 2018 Oct; 9(4):408-414. PubMed ID: 30233794
[TBL] [Abstract][Full Text] [Related]
16. NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer.
Tingle SJ; Severs GR; Goodfellow M; Moir JA; White SA
J Surg Oncol; 2018 Sep; 118(4):680-686. PubMed ID: 30196571
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Nomogram for Disease-Specific Survival in Patients with Pancreatic Ductal Adenocarcinoma of the Head of the Pancreas Following Pancreaticoduodenectomy.
Li HB; Zhou J; Zhao FQ
Med Sci Monit; 2018 Sep; 24():6313-6321. PubMed ID: 30198517
[TBL] [Abstract][Full Text] [Related]
19. Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real-world study.
Hang J; Wu L; Zhu L; Sun Z; Wang G; Pan J; Zheng S; Xu K; Du J; Jiang H
Cancer Med; 2018 Jul; 7(7):2974-2984. PubMed ID: 29856121
[TBL] [Abstract][Full Text] [Related]
20. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
